Lumena raises $23M to advance liver-disease drug

05/9/2013 | American City Business Journals

A Series A funding round has brought in $23 million to Lumena Pharmaceuticals, a California-based biotech firm founded by Pappas Ventures. Proceeds will go toward the development of the company's lead drug candidate for cholestatic liver disease. Lumena plans to conduct midstage trials of the drug in adults with primary biliary cirrhosis and in children with alagille syndrome and progressive familial intrahepatic cholestasis.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC